Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience

BACKGROUND/AIM: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional immunosuppressive agents. The aim of this study is to assess the efficacy and safety...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Turk J Med Sci
Hauptverfasser: KILIÇ, Levent, KARADAĞ, Ömer, ERDEN, Abdulsamet, SARI, Alper, ARMAĞAN, Berkan, YARDIMCI, Gözde Kübra, FIRAT, Esra, KALYONCU, Umut, APRAŞ BİLGEN, Şule, KİRAZ, Sedat, ERTENLİ, İhsan, AKDOĞAN, Ali
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Scientific and Technological Research Council of Turkey 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080363/
https://ncbi.nlm.nih.gov/pubmed/31655524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-1906-39
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge